[Drug Strategies in the Treatment of Chronic Pain: Fokus on Hyperalgesic Effective Strategies].

Throughout Europe, chronic pain syndromes occur with a point prevalence of about 20%, with somatic, psychological, and social factors playing a significant role for their development. Therefore, a careful evaluation of the interaction of these factors is the decisive step for a successful therapy. New insights into pathophysiological processes associated with chronic pain have led to an increasing differentiation of drug and non-drug strategies. These strategies take individual factors into account and aim on influencing the neural network for chronic pain. The drugs used are chosen on the basis of pathophysiological findings and specific drug effects. Adjunctive agents are often used in the management of chronic pain. Knowledge of anti-allodynic and anti-hyperalgesic drugs such as antidepressants and anticonvulsants increases continuously and is therefore presented in more detail in the present study.

[1]  T. Tölle,et al.  Duloxetine use in chronic painful conditions – individual patient data responder analysis , 2013, European journal of pain.

[2]  Michael Schünke,et al.  PROMETHEUS LernAtlas der Anatomie , 2014 .

[3]  Ronald S Duman,et al.  New paradigms for treatment‐resistant depression , 2013, Annals of the New York Academy of Sciences.

[4]  M. Schuers,et al.  Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews , 2013, BMC Family Practice.

[5]  H. Göbel.  [Innovative integrated and coordinated care in pain therapy]. , 2013, Schmerz.

[6]  H. Göbel.  Innovative Versorgungsformen in der Schmerztherapie , 2013, Der Schmerz.

[7]  C. Argoff.  Topical analgesics in the management of acute and chronic pain. , 2013, Mayo Clinic proceedings.

[8]  H. Gerbershagen.  [Transition from acute to chronic postsurgical pain. Physiology, risk factors and prevention]. , 2013, Schmerz.

[9]  M. Karst,et al.  Ca++/CaMKII switches nociceptor‐sensitizing stimuli into desensitizing stimuli , 2012, Journal of neurochemistry.

[10]  A. Dahan,et al.  Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain , 2012, Expert opinion on drug metabolism & toxicology.

[11]  E. Tam,et al.  Transdermal Lidocaine and Ketamine for Neuropathic Pain: A Study of Effectiveness and Tolerability , 2012, The open neurology journal.

[12]  W. Häuser,et al.  [Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline]. , 2012, Schmerz.

[13]  B. Orser,et al.  The Prevention of Chronic Postsurgical Pain Using Gabapentin and Pregabalin: A Combined Systematic Review and Meta-Analysis , 2012, Anesthesia and analgesia.

[14]  C. Klötzsch,et al.  Leitlinien für Diagnostik und Therapie in der Neurologie , 2012 .

[15]  E. Kalso,et al.  A new definition of neuropathic pain , 2011, PAIN®.

[16]  C. Woolf.  Central sensitization: Implications for the diagnosis and treatment of pain , 2011, PAIN.

[17]  George Kollias,et al.  Blockade of TNF-α rapidly inhibits pain responses in the central nervous system , 2011, Proceedings of the National Academy of Sciences.

[18]  P. Langley,et al.  The prevalence, correlates and treatment of pain in the European Union , 2011, Current medical research and opinion.

[19]  P. Langley,et al.  The impact of pain on labor force participation, absenteeism and presenteeism in the European Union , 2010, Journal of medical economics.

[20]  A. Serretti,et al.  Antidepressants and body weight: a comprehensive review and meta-analysis. , 2010, The Journal of clinical psychiatry.

[21]  T. Jensen,et al.  The evidence for pharmacological treatment of neuropathic pain , 2010, PAIN.

[22]  C. Maihöfner,et al.  Neuropathische Schmerzsyndrome und Neuroplastizität in der funktionellen Bildgebung , 2010, Der Schmerz.

[23]  B. Nagel,et al.  Effektivität intensiver multimodaler Schmerztherapie-Programme , 2010, Der Schmerz.

[24]  Roja Rahimi,et al.  Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. , 2009, World journal of gastroenterology.

[25]  D. Silove,et al.  A Study of the Protective Function of Acute Morphine Administration on Subsequent Posttraumatic Stress Disorder , 2009, Biological Psychiatry.

[26]  R. Sansone,et al.  Pain, pain, go away: antidepressants and pain management. , 2008, Psychiatry (Edgmont (Pa. : Township)).

[27]  R. Hargreaves,et al.  Advances in the pharmacologic treatment of tension-type headache , 2008, Current pain and headache reports.

[28]  P. Moayyedi,et al.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.

[29]  G. McCleane.  Antidepressants as Analgesics , 2008, CNS drugs.

[30]  H. Diener,et al.  Akuttherapie und Prophylaxe der Migräne , 2008, Nervenheilkunde.

[31]  G. Spielmans.  Duloxetine Does Not Relieve Painful Physical Symptoms in Depression: A Meta-Analysis , 2007, Psychotherapy and Psychosomatics.

[32]  J. Farrar,et al.  Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.

[33]  M. Stein,et al.  Pain in the aftermath of trauma is a risk factor for post-traumatic stress disorder , 2007, Psychological Medicine.

[34]  M. Greaves.  Recent advances in pathophysiology and current management of itch. , 2007, Annals of the Academy of Medicine, Singapore.

[35]  Peter Henningsen,et al.  Management of functional somatic syndromes , 2007, The Lancet.

[36]  R. Kerns,et al.  Meta-analysis of psychological interventions for chronic low back pain. , 2007, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[37]  K. Demyttenaere,et al.  The association of depression and painful physical symptoms–a review of the European literature , 2006, European Psychiatry.

[38]  M. Sise,et al.  Long-term posttraumatic stress disorder persists after major trauma in adolescents: new data on risk factors and functional outcome. , 2005, The Journal of trauma.

[39]  W. Häuser,et al.  Funktionelle somatische Schmerzsyndrome , 2004, Der Schmerz.

[40]  S. E. Stewart,et al.  Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. , 2003, The American journal of psychiatry.

[41]  B. Habermeyer,et al.  [Glutamate antagonists for treatment of neuropathic pain]. , 2003, Schmerz.

[42]  F. Block,et al.  Glutamatantagonisten bei neuropathischen Schmerzen , 2003, Der Schmerz.

[43]  R. Pabst,et al.  Postnatally induced differences in adult pain sensitivity depend on genetics, gender and specific experiences: reversal of maternal deprivation effects by additional postnatal tactile stimulation or chronic imipramine treatment , 2002, Behavioural Brain Research.

[44]  S. Schreiber,et al.  Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression? , 2002, Journal of molecular neuroscience : MN.